awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33628778-2F6D6991-CCDB-48EF-990F-FCC3C4EA8A14
Q33628778-2F6D6991-CCDB-48EF-990F-FCC3C4EA8A14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-2F6D6991-CCDB-48EF-990F-FCC3C4EA8A14
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
P2860
Q33628778-2F6D6991-CCDB-48EF-990F-FCC3C4EA8A14
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-2F6D6991-CCDB-48EF-990F-FCC3C4EA8A14
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f8307e718707124915f6d3f544361743de8bb8f
P2860
The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.